<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T21:29:54Z</responseDate>
  <request identifier="oai:figshare.com:article/34028988" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34028988</identifier>
        <datestamp>2026-09-30T03:44:54Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Additional file 3 of Predictors at diagnosis for initiation of biologic or targeted synthetic disease-modifying anti-rheumatic drugs in patients with spondyloarthritis and psoriatic arthritis</dc:title>
          <dc:creator>Mohaned A. Hameed (25140627)</dc:creator>
          <dc:creator>Sofia Exarchou (3445268)</dc:creator>
          <dc:creator>Ankita Sharma (3183054)</dc:creator>
          <dc:creator>Ulf Bergström (503462)</dc:creator>
          <dc:creator>Jon T. Einarsson (25140630)</dc:creator>
          <dc:creator>Carl Turesson (12603)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Psoriatic arthritis</dc:subject>
          <dc:subject>Spondyloarthritis</dc:subject>
          <dc:subject>Biologic DMARDs</dc:subject>
          <dc:subject>Treatment initiation</dc:subject>
          <dc:subject>Predictive factors</dc:subject>
          <dc:subject>Bone marrow edema</dc:subject>
          <dc:description>Supplementary Material 3</dc:description>
          <dc:date>2026-09-29T05:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34028988.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Additional_file_3_of_Predictors_at_diagnosis_for_initiation_of_biologic_or_targeted_synthetic_disease-modifying_anti-rheumatic_drugs_in_patients_with_spondyloarthritis_and_psoriatic_arthritis/34028988</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
